Patent · US Active

Composition composed of ceftriaxone sodium and sulbactum sodium

US10668079B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignees

Inventor

Key dates

Filing dateNov 2, 2016
Grant dateJun 2, 2020
Priority date
Expiry dateNov 2, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D201/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides a composition consisting of ceftriaxone sodium and sulbactam sodium, a pharmaceutical formulation comprising the same and the application thereof. The composition is characterized by having an X-ray powder diffraction pattern with peaks at specific angles. The pharmaceutical formulation according to the present disclosure have better antibacterial activity and stability compared with known compositions, and are thus very suitable for the treatment of bacterial infections, especially for the treatment of refractory urogenital system infections caused by Neisseria gonorrhoeae which has drug-resistance to a variety of antibiotics (β-lactams, tetracyclines, macrolides, fluoroquinolones and aminoglycosides).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.